143 related articles for article (PubMed ID: 12226748)
1. Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency.
Gallagher RC; Hay T; Meniel V; Naughton C; Anderson TJ; Shibata H; Ito M; Clevers H; Noda T; Sansom OJ; Mason JO; Clarke AR
Oncogene; 2002 Sep; 21(42):6446-57. PubMed ID: 12226748
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Apc and p53 synergize to promote mammary neoplasia.
Méniel V; Hay T; Douglas-Jones A; Sansom OJ; Clarke AR
Cancer Res; 2005 Jan; 65(2):410-6. PubMed ID: 15695381
[TBL] [Abstract][Full Text] [Related]
3. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.
Roose J; Huls G; van Beest M; Moerer P; van der Horn K; Goldschmeding R; Logtenberg T; Clevers H
Science; 1999 Sep; 285(5435):1923-6. PubMed ID: 10489374
[TBL] [Abstract][Full Text] [Related]
4. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
5. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice.
Hulit J; Wang C; Li Z; Albanese C; Rao M; Di Vizio D; Shah S; Byers SW; Mahmood R; Augenlicht LH; Russell R; Pestell RG
Mol Cell Biol; 2004 Sep; 24(17):7598-611. PubMed ID: 15314168
[TBL] [Abstract][Full Text] [Related]
7. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
8. TCF transcription factors: molecular switches in carcinogenesis.
Roose J; Clevers H
Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
[TBL] [Abstract][Full Text] [Related]
9. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
11. [The role of APC in colonic cancerogenesis: zeroing in on Myc].
Jeanteur P
Bull Cancer; 1998 Nov; 85(11):925-8. PubMed ID: 9951419
[TBL] [Abstract][Full Text] [Related]
12. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
Hamada F; Bienz M
Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529
[TBL] [Abstract][Full Text] [Related]
13. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
14. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
[TBL] [Abstract][Full Text] [Related]
15. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
16. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
[TBL] [Abstract][Full Text] [Related]
17. Identification of c-MYC as a target of the APC pathway.
He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
19. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]